Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in sun pharma

Equity Indices Remain Range-Bound, Tata Motors Top Gainer

The BSE S&P Sensex closed 45 points or 0.12 per cent at 38,844 while the Nifty 50 gained by 6 points or 0.05 per cent at 11,472.

Read More

Equity Indices End Marginally Lower, Eicher Motors Dips 2.3%

The BSE S&P Sensex wound up 59 points or 0.15 per cent lower at 38,310 while the Nifty 50 closed 8 points or 0.07 per cent down at 11,300.

Read More

Equity Indices Close Flat, Pharma Stocks Hit But PSU Banks Gain

The BSE S&P Sensex wound up 37 points or 0.1 per cent lower at 38,370 while the Nifty 50 lost by 14 points or 0.12 per cent at 11,308.

Read More

Equities On Downward Swing, Reliance Cracks By 1.8%

Sectoral indices at the National Stock Exchange were mixed with Nifty pharma gaining by 3.5 per cent and PSU bank by 1.4 per cent.

Read More

Equity indices in the red, pharma and banking scrips dip

Equity indices in the red, pharma and banking scrips dip

Read More

Equity Indices On Upswing, HDFC Bank Gains 4 Pc Post Q1 Results

Equity Indices On Upswing, HDFC Bank Gains 4 Pc Post Q1 Results

Read More

Sun Pharma's Board Aprroves Share Buyback Worth Rs 1,700 Cr

Shares of Sun Pharmaceutical Industries were trading at Rs 380.70 per scrip on BSE, up 3.23 per cent from its previous close.

Read More

India's Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

The U.S. Food and Drug Administration announced the first coronavirus-related drug shortage in the United States but declined to name the drug in question.

Read More

Sensex Ends 182 Points Higher; RIL Up 2 Per Cent

After scaling a lifetime (intra-day) high of 40,816.38, the 30-share index ended 181.94 points or 0.45 per cent, higher at 40,651.64.

Read More

Sun Pharma: Global Is Local

‘We are meticulously nurturing the specialty business and have built a portfolio of about 10 specialty products’

Read More

Sun Pharma Tumbles After Report Of Probe

Markets regulator Securities and Exchange Board of India (SEBI) is likely to reopen an insider trading case against Sun, media sources reported

Read More

Sensex Rebounds On Value-Buying In Beaten Down Stocks, RIL Leads Recovery

BSE Sensex recovered at 224.50 points to end at 38,242.81 on value buying in hammered stocks led by RIL and Sun Pharma

Read More

The Fight Is On

Sun Pharma’s Dilip Shanghvi is all set to conquer the new normal

Read More

Market Moves With Caution, RBI Rate Call Takes Centre-stage

Major stocks that rose include Sun Pharma, PowerGrid, Dr Reddy's and RIL, jumping up to 3.47 per cent

Read More

Liquidity Worries Haunt Stocks, Sensex, Nifty Stay Soft

The mood at the outset was one of bullishness, given a gap-up opening, but bears took charge during the last half an hour of trade

Read More